1.A case of relapsed minimal-change nephrotic syndrome with multiple brain infarction.
Jun YOON ; Chi Youl KIM ; Min Joon CHOI ; Hyeong Eun LIM ; Moon Jae KIM
Korean Journal of Nephrology 1991;10(2):228-233
No abstract available.
Brain Infarction*
;
Brain*
;
Nephrotic Syndrome*
2.Effect of Preoperative Chemotherapy.
Jae Kyung LEE ; Hyeong Soo CHOI ; Ki Woong SUNG ; Hee Young SHIN ; Hyo Seop AHN
Korean Journal of Pediatric Hematology-Oncology 1997;4(1):105-117
BACKGROUND: The survival rate of children with neuroblastoma has been improved over 20 years, excluding the metastatic disease, in which it does not exceed 20% so far. New treatment modalities have been developed to improve the outcome in metastatic disease. Preoperative chemotherapy reduce the size, the vascularity and the adhesiveness, so increase the resectability of the primary tumor. This retrospective clinical study was designed to review the survival rate in neuroblastoma and to analyze the effect of preoperative chemotherapy in the view point of neoadjuvant therapy on long-term survival in advanced disease. METHODS: One hundred and thirty-four cases were reviewed from 135 patients with neuroblastoma registered at the Department of Pediatrics in Seoul National University Children's Hospital from January, 1985 till December, 1995. The survival rate was reviewed according to the stage. The age, sex of the patients, the stage, anatomical site of the tumor, the level of serum ferritin and neuron-specific enolase were analyzed for the risk factors on survival. RESULTS: Ranges of age at diagnosis were from 1 month to 166 months with the median of 39 months. Five year survival rates and five year disease-free survival rates were 100%, 100% in stage 1(n=5), 90.9%, 90.9% in stage 2(n=13), 43.4%, 40.6% in stage 3(n=19), 27.1%, 19.8% in stage 4(n=95) and 100%, 100% in stage 4S(n=2), respectively. In stage 3, five year survival rate was 52.5% in group receiving neoadjuvant chemotherapy, 28.6% in control group(P=0.02). Five year disease-free survival rate was also noted as 48.6%, 28.6% in each group(P=0.02). In stage 4, five year and ten year survival rates were 27.6%, 23.6% in group receiving neoadjuvant chemotherapy, 26.9%, 0% in control group(P=0.02). Five year and ten year disease-free survival rates were 14.3%, 14.3% in group receiving neoadjuvant chemotherapy, 20%, 0% in control group (P=0.11). In univariate analysis, the age, the stage, and the site of primary tumor appeared to affect the long-term survival. CONCLUSION: Neoadjuvant chemotherapy and delayed primary surgery contribute for advance in survival in advanced neuroblastoma via increasing the resectability of the primary tumor.
Adhesiveness
;
Child
;
Diagnosis
;
Disease-Free Survival
;
Drug Therapy*
;
Ferritins
;
Humans
;
Neoadjuvant Therapy
;
Neuroblastoma
;
Pediatrics
;
Phosphopyruvate Hydratase
;
Retrospective Studies
;
Risk Factors
;
Seoul
;
Survival Rate
3.Clinical Analysis and Treatment of Cervical Spine Injury.
Eui Jung KIM ; Weon Gyu CHOI ; Hyeong Geun JOO ; Hyeong Bong MOON ; Jae Hoon CHO ; Chang Won CHO ; Sung Moon YOON
Journal of Korean Neurosurgical Society 1997;26(3):394-400
This study analyzed 88 patients who sustained a cervical spine injury during the past 4 years(Jan, 1993-May, 1996) in whom had 33 anterior, 21 posterior interventions were underwent and 34 remaining patients recieved conservative treatment with halovest. In 45 cases of upper cervical injuries, 16 operations were done. Among these, anterior approach was used in 3 patients and posterior approach in 13 patients. In 43 cases of lower cervical injuries, 39 operations were done. The anterior approach was used in 30 patients, posterior approach in 9 patients, and bilateral approached in remaing 4 cases. For patients with a predominent posterior ligamentous or osteoligamentous lesion, we selected anterior approach, when closed reduction was possible. Whenever the facet joint remained interlocked, a posterior approach was chosen. This report does not mentioned priority of anterior procedure at any case. Although clinical experience does not support the experimental data, we examined the reliability of anterior approach with use of internal fixation.
Humans
;
Ligaments
;
Spine*
;
Zygapophyseal Joint
4.Industrial Accident Compensation Insurance Benefits on Cerebrovascular and Heart Disease in Korea.
Hyeong Su KIM ; Jae Wook CHOI ; Soung Hoon CHANG ; Kun Sei LEE
Journal of Korean Medical Science 2003;18(4):483-488
The purpose of this study is to present the importance of work-related cerebrovascular and heart disease from the viewpoint of expenses. Using the insurance benefit paid for the 4,300 cases, this study estimated the burden of insurance benefits spent on work-related cerebrovascular and heart disease. The number of cases with work-related cerebrovascular and heart disease per 100,000 insured workers were 3.36 in 1995; they were increased to 13.16 in 2000. By the days of occurrence, the estimated number of cases were 1,336 in 2001 (95% CI: 1,211-1,460 cases) and 1,769 in 2005 (CI: 1,610-1,931 cases). The estimated average insurance benefits paid per person with work-related cerebrovascular and heart disease was 75-19 million won for medical care benefit and 56 million won for other benefits except medical care. By considering the increase in insurance payment and average pay, the predicted insurance benefits for work-related cerebrovascular and heart disease was 107.9 billion won for the 2001 cohort and 192.4 billion won for the 2005 cohort. From an economic perspective, the results will be used as important evidence for the prevention and management of work-related cerebrovascular and heart disease.
*Accidents
;
*Accidents, Occupational
;
Brain Diseases/epidemiology
;
Cohort Studies
;
Compensation and Redress
;
Costs and Cost Analysis
;
Heart Diseases/epidemiology
;
Human
;
*Insurance Benefits
;
Insurance Coverage
;
Korea
;
Linear Models
;
Models, Statistical
;
*Occupational Health
;
Sensitivity and Specificity
;
Time Factors
;
*Workers' Compensation
5.A STUDY ON THE SURFACE ROUGHNESS OF GLAZED PORCELAIN AND POLISHED PORCELAIN.
Mee Ra CHOI ; Hun Young CHUNG ; Sun Hyeong LEE ; Jae Ho YANG
The Journal of Korean Academy of Prosthodontics 1998;36(4):549-565
Porcelain is considered to be one of the materials of choice for restoration where esthetics is of concern. But porcelain surface without final glazing treatment may induce undesirable results such as inflammatory respones on adjacent soft tissues due to plaque accumulation and increased wear of opposing teeth. Therefore, rough porcelain surface must be smoothened by final glazing treatment or chairside polishing procedure. The purpose of this study was to compare the surface roughness among self-glazed, overglazed and polished porcelain with various polishing kit, and to detect which phase of polishing is optimal in clinic. Specimens were fabricated with Vita VMK porcelain. The surface treatment of each group was performed as follows. Group 1 : overglazing treatment Group 2 : self-glazing treatment Group 3 : polishing with the Truluster Polishing System for Porcelain(Brasseler, U.S.A.) Group 4 : polishing with the Exa Cerapol Adjustment kit (Edenta dental products, Switzerland) followed by finishing with diamond-filled polishing paste Group 5 : polishing with the Shofu Porcelain Adjustment kit (Shofu inc., Japan) followed by finishing with diamond-filled polishing paste. At each polishing steps, the measurement of Ra and Rq values were performed, and the surface was examined by scanning electron microscope. The results were as follows: 1. Overglazing treatment brought smoother surface than self-glazing treatment. 2. Polishing systems without porcelain polishing paste did not make better result than self-glazing treatment. 3. Polishing system with porcelain polishing paste made similar result to overglazing treatment. 4. Applying diamond-filled polishing paste after using polishing system which has porcelain polishing paste produced surface as smooth as overglazing treatment does.
Dental Porcelain*
;
Esthetics
;
Tooth
6.correlation between the concentrations of follicular fluid epidermal growth factor and estradiol in IVF program.
Hyeong Soon KIM ; Sung Sik HAN ; Kyung Hwan CHANG ; In Cheol CHOI ; Won Il PARK ; Dong Jae CHO ; Chan Ho SONG
Korean Journal of Fertility and Sterility 1993;20(3):209-216
No abstract available.
Epidermal Growth Factor*
;
Estradiol*
;
Female
;
Follicular Fluid*
7.A Case of Severe Midventricular Obstructive Hypertrophic Cardiomyopathy with Apical Aneurysmal Dilatation.
Sang Phil NOH ; Jae Hyeong PARK ; Hyeong Seo PARK ; Yong Kue PARK ; Min Soo LEE ; Soo Jin PARK ; Jae Hwan LEE ; Si Wan CHOI ; In Whan SEONG
Journal of the Korean Society of Echocardiography 2005;13(3):117-120
Midventricular obstructive hypertrophic cardiomyopathy (MOHCM) is a rare variant of hypertrophic cardiomyopathy. Apical dilatation and myocardial infarction can be complicated without significant coronary artery disease. We report a case of apical dilatation in a patient with MOHCM without atherosclerotic coronary artery disease. A 76-year-old woman was admitted for recent cerebral infarction and consulted to cardiologist for abnormal electrocardiographic findings. She had been suffering from exertional dyspnea (NYHA II) for about four years. Two dimentional-echocardiography revealed midventricular obstructive hypertrophy with an apical dilatation and paradoxical jet flow from the apical aneurysm to the left ventricular outflow tract during early diastole. Cardiac catheterization demonstrated dyskinesia in the apical wall with midventricular obstruction and a peak-to-peak intraventricular pressure gradient of 110 mmHg during pull-back from the apical high-pressure chamber to the subaortic low-pressure chamber in the left ventricle. Coronary angiograms showed no significant stenotic lesion of the coronary arteries. She was prescribed oral beta-adrenergic antagonist to decrease the intraventricular pressure gradient.
Aged
;
Aneurysm*
;
Cardiac Catheterization
;
Cardiac Catheters
;
Cardiomyopathy, Hypertrophic*
;
Cerebral Infarction
;
Coronary Artery Disease
;
Coronary Vessels
;
Diastole
;
Dilatation*
;
Dyskinesias
;
Dyspnea
;
Electrocardiography
;
Female
;
Heart Ventricles
;
Humans
;
Hypertrophy
;
Myocardial Infarction
;
Ventricular Pressure
8.The Clinical Feasibility of Transradial Coronary Intervention in Selective Patients Undergoing Left Main Coronary Intervention.
Yong Kyu PARK ; Jae Hyeong PARK ; Jae Hwan LEE ; Hyeong Seo PARK ; Min Soo LEE ; Soo Jin PARK ; Si Wan CHOI ; Jin Ok JEONG ; In Whan SEONG
Korean Circulation Journal 2006;36(11):732-736
BACKGROUND AND OBJECTIVES : The transradial approach has been increasingly used as an alternative to conventional transfemoral intervention. However, there is little data on the efficacy of transradial coronary intervention (TRI) in left main coronary arterial (LMCA) disease. The purpose of this study was to evaluate the feasibility of TRI in selective patients undergoing percutaneous coronary intervention (PCI) for LMCA disease. SUBJECTS AND METHODS : Between Jan 2003 and May 2005, 83 patients with LMCA stenosis were treated with PCI. Of these, 40 selected patients having undergone TRI were included in this study. RESULTS : The patients included 30 males and 10 females, with a mean age of 61+/-12 years. There were 28 cases (70%) involving coronary arteries other than the LMCA and 24 cases (60%) with bifurcation lesion involvement. In 28 cases (70%), a 6 Fr sized guiding catheter was used. No case required crossover from TRI to TFI due to procedural failure. During hospitalization, 2 patients who underwent primary PCI in the setting of STEMI died, but there were no other clinical events. CONCLUSION : In selected patients with LMCA disease, TRI can be a feasible and safe approach for PCI.
Angioplasty, Balloon, Coronary
;
Catheters
;
Constriction, Pathologic
;
Coronary Disease
;
Coronary Vessels
;
Female
;
Hospitalization
;
Humans
;
Male
;
Percutaneous Coronary Intervention
;
Radial Artery
9.A Case of Chronic Active Hepatitis Developed in Patient with Psoriasis after Long-term Methotrexate Treatment.
Dae Hyun KIM ; Jae Hyun JO ; Min Su KEUM ; Seong Gon CHOI ; Chang Hyeong LEE ; Young Oh KWEON ; Sung Kook KIM ; Yong Whan CHOI ; Joon Mo CHUNG
The Korean Journal of Hepatology 1997;3(1):78-84
Methotrexate (MTX) has been widely used in the treatment of psoriasis and rheumatoid arthritis. But prolonged use of MTX can induce hepatic fibrosis and even cirrhosis. To date, in Korea, there have been very few reports on hepatotoxicity due to MTX, and no report on biopsy-proven chronic active hapatitis. We report one patient who developed chronic acitve hepatitis while taking long-term daily dose of MTX(10mg per day) for psoriasis for a prolonged period.
Arthritis, Rheumatoid
;
Fibrosis
;
Hepatitis
;
Hepatitis, Chronic*
;
Humans
;
Korea
;
Methotrexate*
;
Psoriasis*
10.A Familial Case of beta-Thalassemia Minor due to a Point Mutation (G-->A) at Position 1 in the Second Intervening Sequence.
Jae Hong CHOI ; Ki Hyeong LEE ; Seung Taik KIM ; Youn Mi CHOI ; Sung Sup PARK ; Han Ik CHO
Korean Journal of Hematology 1997;32(2):306-311
The thalassemias are congenital disorders in which globin chains are present in decreased amount or absent. Beta-thalassemia, a quite common disorder in Central Africa, the Middle East, and Southeast Asia, has been reported sporadically in Korea since 1988, and some mutations have been identified. We recently analyzed the beta-gene complexes of a family diagnosed with beta-thalassemia minor. The patient was a 20-year-old female who visited our hospital because of anemia and jaundice since her childhood. Through blood tests and hemoglobin electrophoresis, she was diagnosed as having beta-thalassemia minor. Subsequently, DNAs from the patient and her parents were analyzed in search of mutations in beta-gene complex. It was revealed that the patient and her father, a 50-year-old male, have G to A substitutions at position 1 in the second intervening sequence (IVS II-1, G-->A). The mutation was associated with silent mutation of C to T substitution at the codon 91 (CTG-->TTG). To our knowledge, this mutation has not been previously reported in Korea.
Africa, Central
;
Anemia
;
Asia, Southeastern
;
beta-Thalassemia*
;
Codon
;
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
;
DNA
;
Electrophoresis
;
Fathers
;
Female
;
Globins
;
Hematologic Tests
;
Humans
;
Introns*
;
Jaundice
;
Korea
;
Male
;
Middle Aged
;
Middle East
;
Parents
;
Point Mutation*
;
Thalassemia
;
Young Adult